According to Medpace's latest financial reports the company has $0.24 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.24 B | 768.38% |
2022-12-31 | $28.26 M | -93.87% |
2021-12-31 | $0.46 B | 66.08% |
2020-12-31 | $0.27 B | 110.56% |
2019-12-31 | $0.13 B | 466.79% |
2018-12-31 | $23.27 M | -12.12% |
2017-12-31 | $26.48 M | -28.61% |
2016-12-31 | $37.09 M | 149.32% |
2015-12-31 | $14.88 M | -72.59% |
2014-12-31 | $54.28 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -15.18% | ๐บ๐ธ USA |